Researchers at Weill Cornell Medicine have discovered that neutrophils, a type of white blood cell, play a critical role in eradicating solid tumors. This finding is surprising because neutrophils are part of the innate immune system and are not known for targeting specific antigens like T cells.
The path to personalized cancer treatment — Researchers identify genetic markers of drug sensitivity in cancer cells – Recently researchers have profiled genetic changes in cancer with drug sensitivity in order to develop a personalised approach to cancer treatments. They uncovered hundreds of associations between mutations in cancer genes and sensitivity to anticancer drugs.
Cancer scientists discover new way breast cancer cells adapt to environmental stress – An international research team led by Dr. Tak Mak, Director, The Campbell Family Institute for Breast Cancer Research at Princess Margaret Hospital (PMH), has discovered a new aspect of “metabolic transformation”, the process whereby tumour cells adapt and survive under conditions that would kill normal cells.
Study shows further benefits of noscapine for prostate cancer – Noscapine, cough medicine ingredient, can be used as a prophylactic treatment for prostate cancer. The new study shows that noscapine inhibited tumor growth in mice and also limited the spread of tumors without causing any side effects.
Ovarian cancer tests flawed, in need of new design, says Stanford study — Tiny early stage ovarian tumors define early detection challenge. – Current diagnostic tests for ovarian cancer are woefully ineffective for early detection of the disease, say researchers at Stanford University School of Medicine.
American Cancer Society awards 143 research grants to investigators at 83 institutions nationwide. Grants total more than $51 million in the second of two cycles for 2009. – The American Cancer Society, the largest non-government, not-for-profit funding source of cancer research in the United States, has awarded 143 national research and training grants totaling more than $51 million in the second of two grant cycles for 2009. The grants go into effect beginning July 1, 2009.
Vitamin C supplements may reduce benefit from wide range of anti-cancer drugs – In pre-clinical studies, vitamin C appears to substantially reduce the effectiveness of anticancer drugs, say researchers at Memorial Sloan-Kettering Cancer Center.
Drinking grapefruit juice, orange and apple juices with certain drugs could lower their effectiveness by decreasing the absorption of drugs, potentially wiping out their beneficial effects. – Grapefruit and other common fruit juices, including orange and apple, decrease the absorption of drugs, potentially wiping out their beneficial effects.